Webinar: Improving the Language and Coverage of Addiction

Addiction Treatment Week Logo

In this webinar, in reflecting new scientific understanding of addiction, the speakers will offer guidance on how the media can accurately and fairly cover addiction through language, point-of-view, and style. The medical understanding of addiction and the science behind the disease has changed significantly. While the medical community changes the way it treats addiction, the media is also changing the way it covers addiction. The webinar will consider the stigma surrounding addiction and how the way the media covers the disease effects the public perception of the disease. Importantly, the webinar also will discuss the recent changes made to the AP Stylebook about the word “addict” and other stigmatizing words.

Sarah Wakeman

MD, FASAM

Sarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, and clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She is the Medical Director of RIZE Massachusetts, a state-wide, private sector initiative created to build a $50 million fund to implement and evaluate innovative interventions to address the opioid overdose crisis. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine. She is chair of the policy committee for the Massachusetts Society of Addiction Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she is chair of the American Society of Addiction Medicine Drug Court Task Force and serves on their ethics committee.Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in medical settings, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care.

Michael P. Botticelli

Executive Director of the Grayken Center for Addiction

Michael Botticelli currently serves as the Executive Director of the Grayken Center for Addiction, Boston Medical Center.  Previously, Mr. Botticelli served as the Acting Director of National Drug Control Policy.  He also served as the Deputy Director of National Drug Control Policy, a position he held since 2012. Mr. Botticelli has more than two decades of experience supporting Americans who have been affected by substance use disorders. Prior to joining ONDCP, Mr. Botticelli served as Director of the Bureau of Substance Abuse Services at the Massachusetts Department of Public Health, where he successfully expanded innovative and nationally recognized prevention, intervention, treatment, and recovery services for the Commonwealth of Massachusetts. He also forged strong partnerships with local, state, and Federal law enforcement agencies; state and local health and human service agencies; and stakeholder groups to guide and implement evidence-based programs. These programs include the establishment of a treatment system for adolescents, early intervention and treatment programs in primary healthcare settings, jail diversion programs, re-entry services for those leaving correctional facilities, and overdose prevention programs. Mr. Botticelli has served in a variety of leadership roles for the National Association of State Alcohol and Drug Abuse Directors. He was also a member of the Advisory Committee for the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Prevention and the National Action Alliance for Suicide Prevention and has also co-authored many peer-reviewed articles that have significantly contributed to the field . In 2008, Mr. Botticelli was the first recipient of the annual Ramstad/Kennedy National Award for Outstanding Leadership in Promoting Addiction Recovery. In 2012, he was awarded the Service Award from the National Association of State Alcohol and Drug Abuse Directors. Born in Upstate New York, Mr. Botticelli holds a Bachelor of Arts from Siena College and a Master of Education from St. Lawrence University. He is also in long-term recovery from addiction, celebrating over 24 years of sobriety.

Jeff McMillan

Eastern US Enterprise Editor, the Associated Press

Jeff McMillan is the East enterprise editor for The Associated Press, guiding investigations and features for one of the world’s largest newsgathering organizations in a region stretching from Ohio to Maine. He is an editor of the AP Stylebook, known as the “bible” for journalists on matters of usage and style, and was the primary author of its guidance on drugs and addiction. He is also the East region’s main consultant on journalistic standards. He is a graduate of the University of Minnesota.

Addiction Medicine:  The Next Generation Webinar Planning Committee 

Name

Disclosure

Peter L. Selby MBBS, CCFP, FCFP, MHSc, DFASAM, (Immediate Past Chair)

Johnson and Johnson: Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support;Pfizer: Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

No Financial Relationships or Conflicts of Interest

Mark P. Schwartz, MD, FAAFP, DFASAMNo Financial Relationships or Conflicts of Interest
Sarah E. Wakeman, MD, FASAMNo Financial Relationships or Conflicts of Interest
Michael Botticelli, Director, Executive Director, Grayken Center for AddictionNo Financial Relationships or Conflicts of Interest
Jeff McMillan, The Associated PressNo Financial Relationships or Conflicts of Interest

ASAM CME Committee 

Name

Disclosure

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

No Financial Relationships or Conflicts of Interest

Catherine Friedman, MD

No Financial Relationships or Conflicts of Interest

Noel Ilogu, MD, MRCP, DFASAM

No Financial Relationships or Conflicts of Interest

Herbert L. Malinoff, MD, FACP, DFASAM

No Financial Relationships or Conflicts of Interest

Edwin A. Salsitz, MD, DFASAM

No Financial Relationships or Conflicts of Interest

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior, Honorarium, Speaker; BDSI, Honorarium, Consultant/SpeakerCommercial Interest Definition


A commercial interest is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

 

Key:

Complete
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video. View the recorded webinar.